AzTrials
AzTrials

General AnesthesiaNCT02002364

Comparison of a Single Use (Ambu aScope) and a Reusable Flexible Optical Scope for Intubation Through a Supraglottic Airway Device (Aura-i)

A study testing tracheal intubation in people with General Anesthesia, run by Copenhagen University Hospital, Rigshospitalet at 2 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In patient who are predicted to be difficult to intubate with a standard direct laryngoscope well use flexible optical intubation via a supraglottic airway devise (the Ambu Aura-i). Patients are randomly assigner to a single- or a multiple- use flexible optical scope. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
General Anesthesia
What is being tested?
tracheal intubation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
2 sitesin 2 countries
Study dates
Nov 2013to Dec 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA physical status 1-3 and evaluated pre-operatively and found suitable for tracheal intubation with a flexible optical scope via the SAD and scheduled for elective surgery/anesthesia and are conscious about their rights and consequences of participating in the study.
  • The patient must have one or two of the following predictors of difficult tracheal intubation:
  • Modified Mallampati score > 2 (= "no parts of the Uvula is visible")
  • a thyromental distance of less then or equal to 6.5 cms
  • Combined movement in head and neck < 90 degrees
  • Mouth-opening less the 4 cm (but must be larger then 2.5 cm)
Show all 10Show fewer
  • Inability to protrude the teeth n the lower jaw beyond the upper incisors
  • BMI > 40 combined with a neck-circumference > 43 cms
  • Upper-lip-bite-test > 2
  • Previous difficult intubation or laryngoscopy (If more then two criteria are fulfilled the patient should be considered intubated awake instead. . But the upper-lip-bite-test and the prognation-beyond the incisors test represents a similar thing, namely the inability to sub-luxate the lower jaw, the if both these findings are positive it is only considered as counting for one.

Who cannot join

  • ASA physical status 4 or 5
  • contraindications for use of the SAD
  • Patients in whom intubation via a SAD has previously failed
  • Patients at risk of aspiration from the gastrointestinal channel
  • diseases in mouth, pharynx or larynx that precludes the use of a SAD
  • Patients in whom the cricothyroid membrane cannot be localized preanaesthetically
  • Patients in whom the doctor making the pre-anaesthetic evaluation finds in need of an awake intubation
  • Patients with possible Creutzfeldt-Jacobs disease or contraindication against the use of non-autoclavable equipment r risk of cross contamination with prions

Trial locations and contacts

2 sites in 2 countries.

Michael S Kristensen, M.D. contact

0045 35458033

michael.seltz.kristensen@regionh.dk

2 sites in 2 countries

Denmark1 site, 1 recruiting
  • Rigshospitalet, Denmark

    Copenhagen, 2100

    Michael S Kristensen, M.D., 0045 3445 8033, michael.seltz.kristensen@regionh.dk

    Michael S Kristensen, M.D.

    Recruiting

Other trials in Denmark

France1 site, 1 recruiting
  • Service d'anesthesie-reanimation 1 avenue Moliere Hopiatl de Hautepierre

    Strasbourg, 67098

    Pierre Diemunsch, M.D., 0033 3 88 12 70 76, pierre.diemunsch@chrustrasbourg.fr

    Pierre Diemunsch, M.D.

    Not yet recruiting

Other trials in France

About this study

Official title: A Comparison Between Flexible Single Use Endoscopes (Ambu aScopes) and Reusable Flexible Endoscopes Used as a Standard of Car When Intubation the Trachea Via an Aura-I Supraglottic Airway Device

In patient who are predicted to be difficult to intubate with a standard direct laryngoscope well use flexible optical intubation via a supraglottic airway devise (the Ambu Aura-i). Patients are randomly assigner to a single- or a multiple- use flexible optical scope.

We hypothesize that intubation is obtained equally effective with both types of flexible scopes

Being tested
tracheal intubation
Keywords
tracheal intubation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tracheal intubationProcedure or surgery

Study groups in NCT02002364
Study groupRoleWhat they receive
Single use flexible optical scopeActive comparatorSingle use flexible optical scope , Ambu aScope
Receives: Procedure: tracheal intubation
Multiple use flexible optical scopeActive comparatorMultiple use flexible optical scope
Receives: Procedure: tracheal intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of intubation. From the endoscope enters the supraglottic-airway-device to CO2-curve is seen

    Measured: Measured during tracheal intubation at induction of anesthesia

Secondary outcomes (9)
  1. Number of attempts at placing the supraglottic-airway-device (SAD)

    an attempt is defined as the tip of the SAD passing the upper front teeth

    Measured: From anesthesia induction and the following 10 minutes during securing of the airway

  2. number of attempts at placing the flexible endoscope in the trachea

    Measured: From anesthesia induction and the following 10 minutes

  3. number of attempts at intubation

    An intubation attempt starts when the tip of the endotracheal tube passes the entrance to the SAD

    Measured: From anesthesia induction and during the following 10 minutes during airway management

  4. Total time for placement of SAD and endoscopy and intubation

    Measured: During induction of anesthesia and the following 10 minutes during airway management

  5. The best glottic view obtained

    Measured: After anesthesia induction and during the following 10 minutes during airway management

  6. The ease of passage of the flexible endoscope via the SAD

    Measured: During induction and airway management

  7. The anesthesiologists' satisfaction with the procedure

    Measured: During induction of anesthesia and within the 30 minutes hereafter

  8. The quality of the endoscopically obtained image

    Measured: During induction of anesthesia and the following 10 minutes during airway management

  9. Postoperative sore throat, dysphonia or dysphagia one hour after extubation

    Measured: AT the time 1 hour after extubation of the trachea

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2013 (estimated)
  2. Study startNov 2013
  3. Primary completionDec 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02002364
Sponsor's protocol ID
Journal nr. H-3-2012-001
Status last verified
May 2014
First submitted
24 Nov 2013
Last updated
21 May 2014
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing tracheal intubation in people with General Anesthesia, run by Copenhagen University Hospital, Rigshospitalet at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 May 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Denmark, France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Michael S Kristensen, M.D. (0045 35458033, michael.seltz.kristensen@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of intubation. From the endoscope enters the supraglottic-airway-device to CO2-curve is seen (time frame: Measured during tracheal intubation at induction of anesthesia). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in